Log in to save to my catalogue

The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance

The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c5a305f11bc34c4794361a1f3228eb51

The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance

About this item

Full title

The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance

Publisher

Birmingham: MDPI AG

Journal title

Transplantology (Basel, Switzerland), 2024-09, Vol.5 (3), p.148-162

Language

English

Formats

Publication information

Publisher

Birmingham: MDPI AG

More information

Scope and Contents

Contents

The functional outcomes and restoration of form after vascularized composite allotransplantation (VCA) have exceeded the results that could be achieved with current autologous surgical techniques. However, the longevity of VCA grafts has been limited due to the development of donor-specific antibodies (DSAs), and chronic rejection and graft failure...

Alternative Titles

Full title

The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c5a305f11bc34c4794361a1f3228eb51

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c5a305f11bc34c4794361a1f3228eb51

Other Identifiers

ISSN

2673-3943

E-ISSN

2673-3943

DOI

10.3390/transplantology5030015

How to access this item